| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 1.04e-08 | 120 | 71 | 8 | GO:0004222 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.16e-08 | 188 | 71 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS12 ADAMTS10 HGF CD5L ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 TMPRSS2 ADAMTS14 CFI | 3.47e-08 | 430 | 71 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 THBS1 THBS2 PCDHA9 SCUBE2 CD248 PCLO LRP4 MATN4 DYSF AGRN FBN3 NOTCH2 RHOT1 | 3.20e-07 | 749 | 71 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | peptidase activity | ADAMTS12 ADAMTS10 USP31 HGF CD5L ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 TMPRSS2 ADAMTS14 CFI | 4.49e-07 | 654 | 71 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | metallopeptidase activity | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 5.46e-07 | 200 | 71 | 8 | GO:0008237 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.86e-06 | 268 | 71 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | heparin binding | 5.39e-06 | 192 | 71 | 7 | GO:0008201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.89e-05 | 323 | 71 | 8 | GO:1901681 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.33e-04 | 73 | 71 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | collagen binding | 1.99e-04 | 81 | 71 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 7.94e-04 | 51 | 71 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.16e-03 | 891 | 71 | 10 | GO:0005198 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS12 ADAMTS10 ADAMTSL1 FN1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 MATN4 ADAMTS14 ADAMTSL3 | 6.69e-09 | 377 | 72 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS12 ADAMTS10 ADAMTSL1 FN1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 MATN4 ADAMTS14 ADAMTSL3 | 6.89e-09 | 378 | 72 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS12 ADAMTS10 ADAMTSL1 FN1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 MATN4 ADAMTS14 ADAMTSL3 | 7.10e-09 | 379 | 72 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | tube morphogenesis | ADAMTS12 HGF FAT4 THBS1 THBS2 FN1 EGFR SDCCAG8 ADGRB2 NTN1 CARD10 DYSF NOTCH2 CD160 | 2.91e-05 | 1125 | 72 | 14 | GO:0035239 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | ADAMTS12 HGF THBS1 THBS2 RPS6KA4 FN1 EGFR ADAMTS7 ADGRB2 LAMA4 LRP4 ADAMTS18 REL NTN1 CARD10 CD160 | 4.29e-05 | 1488 | 72 | 16 | GO:0051241 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 6.00e-05 | 625 | 72 | 10 | GO:0051960 | |
| GeneOntologyBiologicalProcess | chemotaxis | 7.63e-05 | 517 | 72 | 9 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 7.86e-05 | 519 | 72 | 9 | GO:0042330 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.03e-04 | 418 | 72 | 8 | GO:0051962 | |
| GeneOntologyBiologicalProcess | circulatory system development | HGF FAT4 THBS1 THBS2 PCDHA9 FN1 EGFR ADAMTS6 ADGRB2 LAMA4 CARD10 DYSF SLC2A12 NOTCH2 CD160 | 1.13e-04 | 1442 | 72 | 15 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of sodium ion export across plasma membrane | 1.19e-04 | 5 | 72 | 2 | GO:1903276 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.45e-04 | 76 | 72 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | ossification involved in bone maturation | 1.55e-04 | 30 | 72 | 3 | GO:0043931 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 1.88e-04 | 32 | 72 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | bone maturation | 2.06e-04 | 33 | 72 | 3 | GO:0070977 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-1 | 2.23e-04 | 85 | 72 | 4 | GO:0071347 | |
| GeneOntologyBiologicalProcess | animal organ maturation | 2.91e-04 | 37 | 72 | 3 | GO:0048799 | |
| GeneOntologyBiologicalProcess | tube development | ADAMTS12 HGF FAT4 THBS1 THBS2 FN1 EGFR SDCCAG8 ADGRB2 NTN1 CARD10 DYSF NOTCH2 CD160 | 3.03e-04 | 1402 | 72 | 14 | GO:0035295 |
| GeneOntologyBiologicalProcess | bone development | 3.20e-04 | 264 | 72 | 6 | GO:0060348 | |
| GeneOntologyBiologicalProcess | blood vessel development | HGF THBS1 THBS2 FN1 ADAMTS6 ADGRB2 LAMA4 CARD10 DYSF NOTCH2 CD160 | 3.56e-04 | 929 | 72 | 11 | GO:0001568 |
| GeneOntologyBiologicalProcess | vasculature development | HGF THBS1 THBS2 FN1 ADAMTS6 ADGRB2 LAMA4 CARD10 DYSF NOTCH2 CD160 | 5.07e-04 | 969 | 72 | 11 | GO:0001944 |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 FN1 ADAMTS3 CD248 ADAMTS7 ADAMTS6 ADAMTS15 LAMA4 ADAMTS18 NTN1 MATN4 PCOLCE2 NGLY1 ADAMTS14 ADAMTSL3 USH2A AGRN FBN3 | 2.46e-16 | 656 | 72 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 FN1 ADAMTS3 CD248 ADAMTS7 ADAMTS6 ADAMTS15 LAMA4 ADAMTS18 NTN1 MATN4 PCOLCE2 NGLY1 ADAMTS14 ADAMTSL3 USH2A AGRN FBN3 | 2.62e-16 | 658 | 72 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS10 THBS1 THBS2 ADAMTSL1 FN1 ADAMTS3 ADAMTS15 LAMA4 NTN1 MATN4 PCOLCE2 NGLY1 USH2A AGRN | 2.97e-09 | 530 | 72 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 3.98e-06 | 122 | 72 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | cell surface | THBS1 CD5L AJAP1 SCUBE2 CD248 EGFR ADAMTS7 LIPG TRPC4 CXCL9 ADAMTS15 LRP4 ATP1B2 AGRN NOTCH2 | 4.61e-06 | 1111 | 72 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | platelet alpha granule | 3.00e-04 | 93 | 72 | 4 | GO:0031091 | |
| GeneOntologyCellularComponent | fibrinogen complex | 3.23e-04 | 8 | 72 | 2 | GO:0005577 | |
| GeneOntologyCellularComponent | microfibril | 8.90e-04 | 13 | 72 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.60e-03 | 67 | 72 | 3 | GO:0031093 | |
| Domain | TSP_1 | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 1.38e-23 | 63 | 72 | 15 | PF00090 |
| Domain | TSP1 | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 2.33e-23 | 65 | 72 | 15 | SM00209 |
| Domain | TSP1_rpt | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 2.33e-23 | 65 | 72 | 15 | IPR000884 |
| Domain | TSP1 | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 2.33e-23 | 65 | 72 | 15 | PS50092 |
| Domain | Peptidase_M12B_ADAM-TS | ADAMTS12 ADAMTS10 ADAMTSL1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 ADAMTSL3 | 7.10e-19 | 24 | 72 | 10 | IPR013273 |
| Domain | PLAC | ADAMTS12 ADAMTS10 ADAMTSL1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS18 ADAMTS14 ADAMTSL3 | 1.00e-17 | 19 | 72 | 9 | PS50900 |
| Domain | PLAC | ADAMTS12 ADAMTS10 ADAMTSL1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS18 ADAMTS14 ADAMTSL3 | 1.00e-17 | 19 | 72 | 9 | IPR010909 |
| Domain | ADAM_spacer1 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 1.53e-14 | 23 | 72 | 8 | IPR010294 |
| Domain | ADAM_spacer1 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 1.53e-14 | 23 | 72 | 8 | PF05986 |
| Domain | EGF_1 | FAT4 THBS1 THBS2 SCUBE2 FN1 CD248 LAMA4 LRP4 NTN1 MATN4 USH2A AGRN FBN3 NOTCH2 | 8.08e-13 | 255 | 72 | 14 | PS00022 |
| Domain | Peptidase_M12B_N | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 1.83e-12 | 39 | 72 | 8 | IPR002870 |
| Domain | Pep_M12B_propep | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 1.83e-12 | 39 | 72 | 8 | PF01562 |
| Domain | DISINTEGRIN_1 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 2.28e-12 | 40 | 72 | 8 | PS00427 |
| Domain | Reprolysin | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 2.28e-12 | 40 | 72 | 8 | PF01421 |
| Domain | ADAM_MEPRO | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 2.28e-12 | 40 | 72 | 8 | PS50215 |
| Domain | DISINTEGRIN_2 | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 2.28e-12 | 40 | 72 | 8 | PS50214 |
| Domain | Peptidase_M12B | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 2.28e-12 | 40 | 72 | 8 | IPR001590 |
| Domain | Disintegrin_dom | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 2.82e-12 | 41 | 72 | 8 | IPR001762 |
| Domain | EGF-like_CS | FAT4 THBS1 THBS2 SCUBE2 FN1 CD248 LAMA4 LRP4 NTN1 MATN4 AGRN FBN3 NOTCH2 | 1.96e-11 | 261 | 72 | 13 | IPR013032 |
| Domain | EGF_CA | 3.71e-11 | 122 | 72 | 10 | SM00179 | |
| Domain | EGF_CA | 4.07e-11 | 86 | 72 | 9 | PF07645 | |
| Domain | EGF-like_Ca-bd_dom | 4.36e-11 | 124 | 72 | 10 | IPR001881 | |
| Domain | MetalloPept_cat_dom | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 8.40e-10 | 81 | 72 | 8 | IPR024079 |
| Domain | - | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 8.40e-10 | 81 | 72 | 8 | 3.40.390.10 |
| Domain | PLAC | 1.44e-09 | 14 | 72 | 5 | PF08686 | |
| Domain | EGF | FAT4 THBS1 THBS2 SCUBE2 CD248 LAMA4 LRP4 MATN4 AGRN FBN3 NOTCH2 | 1.52e-09 | 235 | 72 | 11 | SM00181 |
| Domain | EGF-like_dom | FAT4 THBS1 THBS2 SCUBE2 CD248 LAMA4 LRP4 MATN4 AGRN FBN3 NOTCH2 | 2.80e-09 | 249 | 72 | 11 | IPR000742 |
| Domain | ZINC_PROTEASE | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 3.90e-09 | 98 | 72 | 8 | PS00142 |
| Domain | EGF_2 | FAT4 THBS1 THBS2 SCUBE2 CD248 LRP4 NTN1 MATN4 AGRN FBN3 NOTCH2 | 5.36e-09 | 265 | 72 | 11 | PS01186 |
| Domain | EGF_3 | 2.23e-08 | 235 | 72 | 10 | PS50026 | |
| Domain | EGF | 2.86e-08 | 126 | 72 | 8 | PF00008 | |
| Domain | Laminin_G | 9.17e-08 | 58 | 72 | 6 | IPR001791 | |
| Domain | Growth_fac_rcpt_ | 1.51e-07 | 156 | 72 | 8 | IPR009030 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.69e-07 | 106 | 72 | 7 | IPR000152 | |
| Domain | CYSTEINE_SWITCH | 4.97e-07 | 41 | 72 | 5 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 6.35e-07 | 43 | 72 | 5 | IPR001818 | |
| Domain | - | 1.76e-06 | 95 | 72 | 6 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 1.99e-06 | 97 | 72 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.24e-06 | 99 | 72 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.38e-06 | 100 | 72 | 6 | PS00010 | |
| Domain | cEGF | 2.85e-06 | 26 | 72 | 4 | IPR026823 | |
| Domain | cEGF | 2.85e-06 | 26 | 72 | 4 | PF12662 | |
| Domain | EGF_LAM_2 | 5.16e-06 | 30 | 72 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 5.16e-06 | 30 | 72 | 4 | PS01248 | |
| Domain | Laminin_EGF | 9.71e-06 | 35 | 72 | 4 | PF00053 | |
| Domain | EGF_Lam | 9.71e-06 | 35 | 72 | 4 | SM00180 | |
| Domain | LAM_G_DOMAIN | 1.36e-05 | 38 | 72 | 4 | PS50025 | |
| Domain | Laminin_EGF | 1.36e-05 | 38 | 72 | 4 | IPR002049 | |
| Domain | LamG | 2.45e-05 | 44 | 72 | 4 | SM00282 | |
| Domain | SRCR | 6.95e-05 | 21 | 72 | 3 | PF00530 | |
| Domain | FacI_MAC | 8.75e-05 | 4 | 72 | 2 | IPR003884 | |
| Domain | FIMAC | 8.75e-05 | 4 | 72 | 2 | SM00057 | |
| Domain | SR | 1.19e-04 | 25 | 72 | 3 | SM00202 | |
| Domain | - | 1.19e-04 | 25 | 72 | 3 | 3.10.250.10 | |
| Domain | SRCR_1 | 1.34e-04 | 26 | 72 | 3 | PS00420 | |
| Domain | SRCR_2 | 1.34e-04 | 26 | 72 | 3 | PS50287 | |
| Domain | TIMP-like_OB-fold | 1.34e-04 | 26 | 72 | 3 | IPR008993 | |
| Domain | SRCR-like_dom | 1.34e-04 | 26 | 72 | 3 | IPR017448 | |
| Domain | TSP_3 | 1.45e-04 | 5 | 72 | 2 | PF02412 | |
| Domain | TSP3 | 1.45e-04 | 5 | 72 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.45e-04 | 5 | 72 | 2 | PS51236 | |
| Domain | - | 1.45e-04 | 5 | 72 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.45e-04 | 5 | 72 | 2 | IPR008859 | |
| Domain | TSP_C | 1.45e-04 | 5 | 72 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.45e-04 | 5 | 72 | 2 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 1.45e-04 | 5 | 72 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 1.45e-04 | 5 | 72 | 2 | IPR028974 | |
| Domain | SRCR | 1.50e-04 | 27 | 72 | 3 | IPR001190 | |
| Domain | hEGF | 1.68e-04 | 28 | 72 | 3 | PF12661 | |
| Domain | ConA-like_dom | 1.99e-04 | 219 | 72 | 6 | IPR013320 | |
| Domain | LDLR_class-A_CS | 4.90e-04 | 40 | 72 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 4.90e-04 | 40 | 72 | 3 | PF02210 | |
| Domain | - | 7.40e-04 | 46 | 72 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 8.39e-04 | 48 | 72 | 3 | PS01209 | |
| Domain | LDLRA_2 | 8.91e-04 | 49 | 72 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 8.91e-04 | 49 | 72 | 3 | IPR002172 | |
| Domain | LDLa | 8.91e-04 | 49 | 72 | 3 | SM00192 | |
| Domain | EGF_3 | 9.43e-04 | 12 | 72 | 2 | PF12947 | |
| Domain | EGF_dom | 9.43e-04 | 12 | 72 | 2 | IPR024731 | |
| Domain | Laminin_N | 1.70e-03 | 16 | 72 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 1.70e-03 | 16 | 72 | 2 | PS51117 | |
| Domain | Laminin_N | 1.70e-03 | 16 | 72 | 2 | PF00055 | |
| Domain | LamNT | 1.70e-03 | 16 | 72 | 2 | SM00136 | |
| Domain | C345C | 1.92e-03 | 17 | 72 | 2 | SM00643 | |
| Domain | PP2C | 2.40e-03 | 19 | 72 | 2 | PF00481 | |
| Domain | NTR | 2.40e-03 | 19 | 72 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 2.40e-03 | 19 | 72 | 2 | IPR018933 | |
| Domain | PP2Cc | 2.66e-03 | 20 | 72 | 2 | SM00332 | |
| Domain | PPM-type_phosphatase_dom | 2.66e-03 | 20 | 72 | 2 | IPR001932 | |
| Domain | - | 2.66e-03 | 20 | 72 | 2 | 3.60.40.10 | |
| Domain | PPM_2 | 2.66e-03 | 20 | 72 | 2 | PS51746 | |
| Domain | TSPN | 3.52e-03 | 23 | 72 | 2 | SM00210 | |
| Domain | NTR | 3.52e-03 | 23 | 72 | 2 | PS50189 | |
| Domain | Netrin_domain | 3.52e-03 | 23 | 72 | 2 | IPR001134 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 1.74e-24 | 39 | 60 | 14 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 1.74e-24 | 39 | 60 | 14 | MM15165 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 NOTCH2 | 1.54e-22 | 68 | 60 | 15 | M27303 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 AGRN NOTCH2 | 5.45e-19 | 143 | 60 | 16 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 1.49e-17 | 109 | 60 | 14 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 1.94e-17 | 111 | 60 | 14 | M27416 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 AGRN NOTCH2 | 4.42e-15 | 250 | 60 | 16 | M27554 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | THBS1 FN1 ADAMTS3 LAMA4 LRP4 ADAMTS18 MATN4 PCOLCE2 ADAMTS14 AGRN FBN3 | 4.58e-08 | 300 | 60 | 11 | M610 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.27e-05 | 258 | 60 | 8 | MM14572 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.73e-05 | 76 | 60 | 5 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.81e-05 | 84 | 60 | 5 | M7098 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.23e-05 | 43 | 60 | 4 | M39565 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.93e-05 | 302 | 60 | 8 | M39719 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 FN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 NGLY1 THSD7B ADAMTS14 ADAMTSL3 RHOT1 | 4.46e-05 | 1389 | 60 | 17 | MM15307 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 6.74e-05 | 326 | 60 | 8 | MM15917 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.77e-05 | 19 | 60 | 3 | MM15512 | |
| Pathway | WP_PI3KAKT_SIGNALING | 8.86e-05 | 339 | 60 | 8 | M39736 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 FN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 NGLY1 THSD7B ADAMTS14 ADAMTSL3 RHOT1 | 9.51e-05 | 1475 | 60 | 17 | M19806 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.13e-04 | 59 | 60 | 4 | M27218 | |
| Pathway | WP_FOCAL_ADHESION | 1.39e-04 | 187 | 60 | 6 | MM15913 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.75e-04 | 66 | 60 | 4 | M18 | |
| Pathway | WP_FOCAL_ADHESION | 1.95e-04 | 199 | 60 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.95e-04 | 199 | 60 | 6 | M7253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION | 2.64e-04 | 6 | 60 | 2 | M47892 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.74e-04 | 30 | 60 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.74e-04 | 30 | 60 | 3 | MM15517 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 3.03e-04 | 31 | 60 | 3 | MM1343 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 3.65e-04 | 33 | 60 | 3 | M277 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 3.65e-04 | 33 | 60 | 3 | M6220 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.96e-04 | 41 | 60 | 3 | M27778 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 7.48e-04 | 42 | 60 | 3 | M174 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 7.84e-04 | 10 | 60 | 2 | M27330 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 8.01e-04 | 43 | 60 | 3 | M53 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.04e-03 | 47 | 60 | 3 | MM14925 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.35e-03 | 113 | 60 | 4 | MM14783 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 1.56e-03 | 54 | 60 | 3 | M42568 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 1.59e-03 | 118 | 60 | 4 | M713 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.21e-03 | 61 | 60 | 3 | MM14637 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 2.61e-03 | 18 | 60 | 2 | M39421 | |
| Pubmed | ADAMTS12 ADAMTS10 THBS1 THBS2 ADAMTSL1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 ADGRB2 ADAMTS15 ADAMTS18 THSD7B ADAMTS14 ADAMTSL3 | 3.76e-26 | 75 | 74 | 15 | 20637190 | |
| Pubmed | 9.50e-12 | 10 | 74 | 5 | 11167130 | ||
| Pubmed | 2.75e-09 | 167 | 74 | 8 | 22159717 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 9.22e-09 | 12 | 74 | 4 | 25770910 | |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 2.53e-08 | 15 | 74 | 4 | 38871984 | |
| Pubmed | Metalloproteinase Adamts16 Is Required for Proper Closure of the Optic Fissure. | 9.22e-08 | 5 | 74 | 3 | 29625437 | |
| Pubmed | 2.63e-07 | 64 | 74 | 5 | 22261194 | ||
| Pubmed | 3.22e-07 | 7 | 74 | 3 | 11867212 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.03e-06 | 248 | 74 | 7 | 24006456 | |
| Pubmed | 1.10e-06 | 10 | 74 | 3 | 7525452 | ||
| Pubmed | 2.08e-06 | 175 | 74 | 6 | 28071719 | ||
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 4.47e-06 | 2 | 74 | 2 | 16181801 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16144838 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17620335 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19959938 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 31589839 | ||
| Pubmed | Alteration of HGF and TSP-1 expression in ovarian carcinoma associated with clinical features. | 4.47e-06 | 2 | 74 | 2 | 22136730 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 34425286 | ||
| Pubmed | Deficiency of CARMA3 attenuates the development of bleomycin induced pulmonary fibrosis. | 4.47e-06 | 2 | 74 | 2 | 34656852 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 4.47e-06 | 2 | 74 | 2 | 8126073 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28263981 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 36376971 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9694593 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26927626 | ||
| Pubmed | PHLPPing through history: a decade in the life of PHLPP phosphatases. | 4.47e-06 | 2 | 74 | 2 | 27913677 | |
| Pubmed | Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. | 4.47e-06 | 2 | 74 | 2 | 22854782 | |
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 4.47e-06 | 2 | 74 | 2 | 10027393 | |
| Pubmed | The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. | 4.47e-06 | 2 | 74 | 2 | 19098927 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18021253 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33981184 | ||
| Pubmed | Ras-associating domain proteins: a new class of cyclic nucleotide-gated channel modulators. | 4.47e-06 | 2 | 74 | 2 | 22183406 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30928339 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22435662 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23288153 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27031829 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17143334 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28476806 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22936342 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 4.47e-06 | 2 | 74 | 2 | 23660684 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 35141985 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24892992 | ||
| Pubmed | Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. | 4.47e-06 | 2 | 74 | 2 | 11941487 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 39122122 | ||
| Pubmed | HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors. | 4.47e-06 | 2 | 74 | 2 | 23045285 | |
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 4.47e-06 | 2 | 74 | 2 | 22930728 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 38339060 | ||
| Pubmed | Thrombospondin-1 and disease progression in dysferlinopathy. | 4.47e-06 | 2 | 74 | 2 | 29206970 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33372257 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21762961 | ||
| Pubmed | Agrin and synaptic laminin are required to maintain adult neuromuscular junctions. | 4.47e-06 | 2 | 74 | 2 | 23056392 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12213711 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 3997886 | ||
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 4.47e-06 | 2 | 74 | 2 | 12358136 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 4.47e-06 | 2 | 74 | 2 | 1712771 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25793736 | ||
| Pubmed | ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. | 4.47e-06 | 2 | 74 | 2 | 27779234 | |
| Pubmed | Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. | 4.47e-06 | 2 | 74 | 2 | 18234969 | |
| Pubmed | EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells. | 4.47e-06 | 2 | 74 | 2 | 28634045 | |
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 4.47e-06 | 2 | 74 | 2 | 18594557 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 38602289 | ||
| Pubmed | Netrin-1-induced activation of Notch signaling mediates glioblastoma cell invasion. | 4.47e-06 | 2 | 74 | 2 | 23549787 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 4.47e-06 | 2 | 74 | 2 | 15037577 | |
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 4.47e-06 | 2 | 74 | 2 | 33759165 | |
| Pubmed | Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis. | 4.47e-06 | 2 | 74 | 2 | 26187040 | |
| Pubmed | Negative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiation. | 4.47e-06 | 2 | 74 | 2 | 22247065 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 5.08e-06 | 16 | 74 | 3 | 17948866 | |
| Pubmed | 6.15e-06 | 17 | 74 | 3 | 10464288 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 7.37e-06 | 18 | 74 | 3 | 35503090 | |
| Pubmed | ADAMTS10 SPOPL SDCCAG8 TRPC4 NSD1 REL HIC2 ADAMTS14 AGRN FBN3 CHRNB4 RHOT1 | 9.30e-06 | 1215 | 74 | 12 | 15146197 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 26241338 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 1.34e-05 | 3 | 74 | 2 | 18787106 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31104010 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18032585 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23653350 | ||
| Pubmed | Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. | 1.34e-05 | 3 | 74 | 2 | 20513427 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 27760826 | ||
| Pubmed | PTEN and PHLPP crosstalk in cancer cells and in TGFβ-activated stem cells. | 1.34e-05 | 3 | 74 | 2 | 32294598 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 11741898 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 30939949 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 14555767 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23846336 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18042364 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24244707 | ||
| Pubmed | The phosphatase PHLPP controls the cellular levels of protein kinase C. | 1.34e-05 | 3 | 74 | 2 | 18162466 | |
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 1.34e-05 | 3 | 74 | 2 | 17442977 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21969364 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19004835 | ||
| Pubmed | Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. | 1.34e-05 | 3 | 74 | 2 | 8463250 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 1.34e-05 | 3 | 74 | 2 | 26168731 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 1.34e-05 | 3 | 74 | 2 | 16598380 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15347840 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 11773026 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 25976449 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19553700 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31092423 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 1.34e-05 | 3 | 74 | 2 | 1459996 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 14667842 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18178577 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 1.34e-05 | 3 | 74 | 2 | 8400410 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q12 | 1.71e-04 | 66 | 74 | 3 | chr5q12 | |
| Cytoband | 2q22.1 | 2.30e-04 | 14 | 74 | 2 | 2q22.1 | |
| Cytoband | 18q21.33 | 3.03e-04 | 16 | 74 | 2 | 18q21.33 | |
| Cytoband | 5q35 | 6.34e-04 | 23 | 74 | 2 | 5q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 2.25e-03 | 160 | 74 | 3 | chr15q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q21 | 4.51e-03 | 205 | 74 | 3 | chr18q21 | |
| Cytoband | 1q41 | 5.14e-03 | 66 | 74 | 2 | 1q41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q22 | 5.77e-03 | 70 | 74 | 2 | chr2q22 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | ADAMTS12 ADAMTS10 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 ADAMTS14 | 3.70e-16 | 19 | 56 | 8 | 50 |
| GeneFamily | ADAMTS like | 1.96e-04 | 7 | 56 | 2 | 947 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 1.24e-03 | 17 | 56 | 2 | 701 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 ADAMTS10 HGF THBS1 THBS2 ADAMTSL1 SCUBE2 FN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 CXCL9 ADAMTS15 LAMA4 ADAMTS18 NTN1 MATN4 PCOLCE2 NGLY1 ADAMTS14 ADAMTSL3 USH2A AGRN FBN3 | 2.77e-17 | 1026 | 74 | 25 | M5889 |
| Coexpression | NABA_MATRISOME | ADAMTS12 ADAMTS10 HGF THBS1 THBS2 ADAMTSL1 SCUBE2 FN1 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 CXCL9 ADAMTS15 LAMA4 ADAMTS18 NTN1 MATN4 PCOLCE2 NGLY1 ADAMTS14 ADAMTSL3 AGRN | 2.84e-15 | 1008 | 74 | 23 | MM17056 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS12 ADAMTS10 ADAMTSL1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 NGLY1 ADAMTS14 ADAMTSL3 | 6.94e-11 | 238 | 74 | 11 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS12 ADAMTS10 ADAMTSL1 ADAMTS3 ADAMTS7 ADAMTS6 ADAMTS15 ADAMTS18 NGLY1 ADAMTS14 ADAMTSL3 | 8.29e-11 | 242 | 74 | 11 | MM17062 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.06e-10 | 196 | 74 | 10 | M3008 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 ADAMTS10 HGF ADAMTSL1 SCUBE2 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 CXCL9 ADAMTS15 ADAMTS18 NGLY1 ADAMTS14 ADAMTSL3 | 1.88e-09 | 738 | 74 | 15 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 ADAMTS10 HGF ADAMTSL1 SCUBE2 ADAMTS3 SEMA5B ADAMTS7 ADAMTS6 CXCL9 ADAMTS15 ADAMTS18 NGLY1 ADAMTS14 ADAMTSL3 | 2.38e-09 | 751 | 74 | 15 | M5885 |
| Coexpression | NABA_CORE_MATRISOME | 5.46e-09 | 275 | 74 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.86e-08 | 191 | 74 | 8 | MM17059 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | FAT4 SCUBE2 FN1 CD248 EGFR SEMA5B ADAMTS7 ADGRB2 ADAMTS15 ADAMTS18 NTN1 CARD10 MATN4 THSD7B DYSF | 2.64e-07 | 1074 | 74 | 15 | M1941 |
| Coexpression | NABA_CORE_MATRISOME | 9.57e-07 | 270 | 74 | 8 | MM17057 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.95e-06 | 40 | 74 | 4 | M5887 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_STROMAL_CELLS | 5.35e-06 | 156 | 74 | 6 | M40151 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_DN | 1.97e-05 | 196 | 74 | 6 | M13256 | |
| Coexpression | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN | 9.17e-05 | 31 | 74 | 3 | M3732 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 1.19e-04 | 89 | 74 | 4 | M40280 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 1.30e-04 | 91 | 74 | 4 | M40180 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.32e-04 | 35 | 74 | 3 | MM17054 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 1.35e-04 | 174 | 74 | 5 | M45676 | |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | 2.04e-04 | 427 | 74 | 7 | M17923 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 2.41e-04 | 439 | 74 | 7 | M39054 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 2.59e-04 | 200 | 74 | 5 | M6625 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.59e-04 | 200 | 74 | 5 | M5930 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | USP31 HGF FAT4 THBS1 THBS2 ADAMTSL1 ADAMTS3 ADAMTS15 NSD1 LAMA4 TMPRSS2 THSD7B PSAPL1 AGRN | 5.73e-07 | 811 | 73 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | ADAMTS12 THBS1 THBS2 FN1 CD248 EGFR ADAMTS15 LAMA4 NTN1 PCOLCE2 | 2.40e-06 | 437 | 73 | 10 | GSM777046_500 |
| CoexpressionAtlas | placenta | HGF FN1 EGFR ADAMTS6 LIPG ADAMTS15 ADAMTS18 PCOLCE2 ADAMTS14 | 3.04e-06 | 349 | 73 | 9 | placenta |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.16e-06 | 261 | 73 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | ADAMTS12 HGF THBS1 THBS2 ADAMTSL1 FN1 CD248 EGFR ADAMTS6 TRPC4 LAMA4 ADAMTS18 PCOLCE2 ADAMTS14 | 4.96e-06 | 975 | 73 | 14 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 4.99e-06 | 127 | 73 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | ADAMTS12 ADAMTS10 FAT4 THBS1 THBS2 ADAMTSL1 FN1 EGFR ADAMTS7 ADGRB2 ADAMTS15 LAMA4 ADAMTS18 NGLY1 CCDC116 | 6.79e-06 | 1148 | 73 | 15 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ADAMTS12 THBS1 ADAMTSL1 FN1 ADAMTS3 CD248 EGFR ADAMTS6 TMPRSS2 ATP1B2 CFI AGRN NOTCH2 | 1.13e-05 | 905 | 73 | 13 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | HGF FAT4 THBS1 THBS2 ADAMTSL1 ADAMTS3 ADAMTS15 TMPRSS2 THSD7B | 1.40e-05 | 422 | 73 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.42e-05 | 250 | 73 | 7 | gudmap_developingKidney_e13.5_podocyte cells_1000_k3 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 2.45e-05 | 453 | 73 | 9 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 2.54e-05 | 455 | 73 | 9 | GSM777055_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | ADAMTS12 ADAMTSL1 FN1 ADAMTS3 CD248 TMPRSS2 ATP1B2 CFI NOTCH2 | 2.58e-05 | 456 | 73 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.89e-05 | 354 | 73 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 3.00e-05 | 356 | 73 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | ADAMTS12 HGF THBS1 FN1 CD248 EGFR LIPG LRP4 REL THSD7B ATP1B2 DCT | 3.01e-05 | 849 | 73 | 12 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | ADAMTS12 ADAMTS10 FAT4 THBS2 ADAMTSL1 FN1 EGFR SEMA5B ADAMTS6 ADGRB2 ADAMTS15 LAMA4 NTN1 NGLY1 | 3.69e-05 | 1166 | 73 | 14 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | USP31 THBS1 THBS2 ADAMTSL1 SCUBE2 LAMA4 TMPRSS2 NTN1 PSAPL1 SLC2A12 AGRN | 6.37e-05 | 774 | 73 | 11 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.71e-05 | 201 | 73 | 6 | Arv_EB-LF_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 7.70e-05 | 407 | 73 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#1 | FAT4 THBS1 MAST4 FN1 ADAMTS6 LAMA4 ADAMTS18 CARD10 LRRC70 CFI DYSF ADAMTSL3 | 7.71e-05 | 936 | 73 | 12 | JC_hmvEC_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 7.84e-05 | 408 | 73 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | ADAMTS12 FAT4 THBS1 THBS2 FN1 ADAMTS3 CD248 EGFR THSD7B ATP1B2 DCT | 8.27e-05 | 797 | 73 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.53e-05 | 305 | 73 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | USP31 HGF FAT4 ADAMTS3 EGFR ADAMTS7 ADAMTS15 LAMA4 ADAMTS18 PSAPL1 AGRN | 9.14e-05 | 806 | 73 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 9.58e-05 | 26 | 73 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.63e-05 | 311 | 73 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 9.74e-05 | 421 | 73 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 1.08e-04 | 219 | 73 | 6 | JC_hmvEC_500_K1 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.09e-04 | 428 | 73 | 8 | JC_hmvEC_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | USP31 HGF FAT4 THBS1 THBS2 ADAMTSL1 ADAMTS3 ADAMTS15 TMPRSS2 THSD7B AGRN | 1.14e-04 | 826 | 73 | 11 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ADAMTS12 HGF NSUN4 FAT4 ADAMTS3 CD248 ADAMTS6 LIPG ADAMTS18 THSD7B ATP1B2 | 1.20e-04 | 831 | 73 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | HGF THBS1 THBS2 ADAMTSL1 FN1 DNAH10 CD248 EGFR ADAMTS15 LAMA4 PCOLCE2 ADAMTS14 | 1.20e-04 | 981 | 73 | 12 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | THBS1 ADAMTSL1 FN1 ADAMTS6 LIPG LAMA4 ADAMTS18 CARD10 LRRC70 DYSF ADAMTSL3 SLC2A12 | 1.31e-04 | 990 | 73 | 12 | JC_hmvEC_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.95e-04 | 466 | 73 | 8 | GSM777050_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | FAT4 THBS2 ADAMTSL1 FN1 ADAMTS3 CD248 EGFR ADAMTS6 DISP1 CHRNB4 | 1.99e-04 | 734 | 73 | 10 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 2.21e-04 | 86 | 73 | 4 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 2.53e-04 | 364 | 73 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 2.54e-04 | 164 | 73 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 2.86e-04 | 493 | 73 | 8 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500 | 2.94e-04 | 495 | 73 | 8 | JC_hmvEC_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.94e-04 | 373 | 73 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.02e-04 | 265 | 73 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 3.14e-04 | 777 | 73 | 10 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | 3.18e-04 | 378 | 73 | 7 | gudmap_developingLowerUrinaryTract_adult_bladder_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#3_top-relative-expression-ranked_200 | 3.22e-04 | 8 | 73 | 2 | gudmap_developingKidney_e15.5_Endothelial cells_200_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 3.55e-04 | 385 | 73 | 7 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 3.72e-04 | 388 | 73 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | ADAMTS12 THBS2 ADAMTSL1 FN1 DNAH10 CD248 ADAMTS6 ADAMTS18 ADAMTS14 DCT FBN3 | 3.84e-04 | 951 | 73 | 11 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | 3.84e-04 | 797 | 73 | 10 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.10e-04 | 182 | 73 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | THBS1 ADAMTS3 SEMA5B ADAMTS7 PCLO SDCCAG8 ATP1B2 AGRN PHLPP2 | 4.13e-04 | 658 | 73 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | USP31 HGF FAT4 ADAMTS3 EGFR ADAMTS15 NSD1 LAMA4 ADAMTS18 AGRN | 4.19e-04 | 806 | 73 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 4.73e-04 | 105 | 73 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | HGF FAT4 THBS1 ADAMTSL1 ADAMTS3 EGFR ADAMTS15 LAMA4 NTN1 RHOT1 | 4.75e-04 | 819 | 73 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 4.76e-04 | 188 | 73 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | ADAMTS12 PLEKHG4B THBS2 ADAMTSL1 FN1 DNAH10 CD248 ADAMTS18 ADAMTS14 DCT FBN3 | 4.98e-04 | 981 | 73 | 11 | Arv_EB-LF_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 5.33e-04 | 412 | 73 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 5.49e-04 | 194 | 73 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#4_top-relative-expression-ranked_500 | 5.62e-04 | 195 | 73 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | THBS2 ADAMTS3 EGFR ADGRB2 ADAMTS15 LAMA4 ADAMTS18 NTN1 THSD7B SLC2A12 | 6.63e-04 | 855 | 73 | 10 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 6.82e-04 | 858 | 73 | 10 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_200 | 6.88e-04 | 116 | 73 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_200_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 7.05e-04 | 432 | 73 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 7.20e-04 | 206 | 73 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_500 | 7.63e-04 | 52 | 73 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | ADAMTS12 ADAMTS10 FAT4 THBS1 THBS2 ADAMTSL1 FN1 SEMA5B ADAMTS7 ADGRB2 LAMA4 NTN1 | 7.97e-04 | 1208 | 73 | 12 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 8.39e-04 | 445 | 73 | 7 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | THBS2 ADAMTSL1 SCUBE2 LAMA4 TMPRSS2 PCOLCE2 ADAMTSL3 PSAPL1 SLC2A12 | 9.02e-04 | 734 | 73 | 9 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | ADAMTS12 ADAMTS10 FAT4 THBS1 ADAMTSL1 FN1 EGFR ADGRB2 LAMA4 LRP4 ADAMTS18 CCDC116 | 9.20e-04 | 1228 | 73 | 12 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.38e-04 | 126 | 73 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 9.55e-04 | 740 | 73 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | THBS1 ADAMTS3 SEMA5B ADAMTS7 PCLO SDCCAG8 NTN1 ATP1B2 PHLPP2 | 9.83e-04 | 743 | 73 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.05e-03 | 336 | 73 | 6 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | 1.11e-03 | 132 | 73 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 1.20e-03 | 231 | 73 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_200 | 1.22e-03 | 61 | 73 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.27e-03 | 234 | 73 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | 1.28e-03 | 772 | 73 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.28e-03 | 479 | 73 | 7 | PCBC_MESO-5_blastocyst_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.31e-03 | 138 | 73 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_500 | 1.31e-03 | 138 | 73 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 1.42e-03 | 783 | 73 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 1.43e-03 | 488 | 73 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.43e-03 | 357 | 73 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 1.45e-03 | 489 | 73 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.46e-03 | 65 | 73 | 3 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_top-relative-expression-ranked_500 | 1.48e-03 | 491 | 73 | 7 | PCBC_MESO-5_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromFibroblast-derived-iPSC_top-relative-expression-ranked_500 | 1.50e-03 | 492 | 73 | 7 | PCBC_DE_fibroblast_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.50e-03 | 243 | 73 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.55e-03 | 793 | 73 | 9 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardioEndothel_top-relative-expression-ranked_500 | 1.55e-03 | 495 | 73 | 7 | PCBC_ctl_CardioEndothel_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_500 | 1.55e-03 | 495 | 73 | 7 | PCBC_ctl_PulmonMicrovasc_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-DefinitiveEndoderm_top-relative-expression-ranked_500 | 1.57e-03 | 496 | 73 | 7 | PCBC_DE_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.66e-03 | 147 | 73 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.67e-03 | 249 | 73 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.74e-03 | 69 | 73 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_500 | 1.74e-03 | 69 | 73 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 1.74e-03 | 371 | 73 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.74e-03 | 149 | 73 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.66e-11 | 199 | 74 | 9 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.87e-11 | 200 | 74 | 9 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.65e-10 | 176 | 74 | 8 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-09 | 191 | 74 | 8 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.55e-09 | 200 | 74 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-09 | 200 | 74 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-09 | 200 | 74 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-09 | 200 | 74 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-08 | 174 | 74 | 7 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.94e-08 | 178 | 74 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-08 | 178 | 74 | 7 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-08 | 182 | 74 | 7 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-08 | 182 | 74 | 7 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 185 | 74 | 7 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 185 | 74 | 7 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 185 | 74 | 7 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.53e-08 | 185 | 74 | 7 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-08 | 186 | 74 | 7 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-08 | 191 | 74 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.15e-08 | 191 | 74 | 7 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-08 | 192 | 74 | 7 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-08 | 193 | 74 | 7 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-08 | 193 | 74 | 7 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-08 | 193 | 74 | 7 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-08 | 193 | 74 | 7 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.38e-08 | 193 | 74 | 7 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-08 | 194 | 74 | 7 | 14b614f039bc866a1348a2728a68b7d254c7748c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-08 | 194 | 74 | 7 | 68c7bfead1158641928cc276f599b4a79e06c73c | |
| ToppCell | facs-SCAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-08 | 194 | 74 | 7 | f6aeae6a1e4017e341323fd4784c9e3bae00552b | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 3.76e-08 | 196 | 74 | 7 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-08 | 196 | 74 | 7 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-08 | 196 | 74 | 7 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 3.76e-08 | 196 | 74 | 7 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.89e-08 | 197 | 74 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.89e-08 | 197 | 74 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.89e-08 | 197 | 74 | 7 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 3.89e-08 | 197 | 74 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-08 | 197 | 74 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.89e-08 | 197 | 74 | 7 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-08 | 198 | 74 | 7 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-08 | 198 | 74 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 4.03e-08 | 198 | 74 | 7 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.03e-08 | 198 | 74 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 4.17e-08 | 199 | 74 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.17e-08 | 199 | 74 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.17e-08 | 199 | 74 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.32e-08 | 200 | 74 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 4.32e-08 | 200 | 74 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.32e-08 | 200 | 74 | 7 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.32e-08 | 200 | 74 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.32e-08 | 200 | 74 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.32e-08 | 200 | 74 | 7 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.06e-07 | 152 | 74 | 6 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.00e-07 | 162 | 74 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-07 | 166 | 74 | 6 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-07 | 166 | 74 | 6 | 1cc291a04f4144abba4aca7badeb7776db05d903 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.72e-07 | 168 | 74 | 6 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-07 | 169 | 74 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.27e-07 | 172 | 74 | 6 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-07 | 175 | 74 | 6 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-07 | 175 | 74 | 6 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-07 | 175 | 74 | 6 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.89e-07 | 176 | 74 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-07 | 177 | 74 | 6 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-07 | 178 | 74 | 6 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.22e-07 | 178 | 74 | 6 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-07 | 178 | 74 | 6 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.40e-07 | 179 | 74 | 6 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.40e-07 | 179 | 74 | 6 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-07 | 179 | 74 | 6 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-07 | 179 | 74 | 6 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-07 | 180 | 74 | 6 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 5.58e-07 | 180 | 74 | 6 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-07 | 180 | 74 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-07 | 180 | 74 | 6 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-07 | 180 | 74 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 5.58e-07 | 180 | 74 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-07 | 181 | 74 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-07 | 181 | 74 | 6 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-07 | 181 | 74 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-07 | 182 | 74 | 6 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.95e-07 | 182 | 74 | 6 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-07 | 182 | 74 | 6 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-07 | 182 | 74 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.95e-07 | 182 | 74 | 6 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.34e-07 | 184 | 74 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.34e-07 | 184 | 74 | 6 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-07 | 185 | 74 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.54e-07 | 185 | 74 | 6 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-07 | 186 | 74 | 6 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.75e-07 | 186 | 74 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.75e-07 | 186 | 74 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.97e-07 | 187 | 74 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-07 | 187 | 74 | 6 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 6.97e-07 | 187 | 74 | 6 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.97e-07 | 187 | 74 | 6 | 8ee3bf885897efd634c3a0567637142a9f55e693 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.19e-07 | 188 | 74 | 6 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.19e-07 | 188 | 74 | 6 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-07 | 188 | 74 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 7.42e-07 | 189 | 74 | 6 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| Drug | chondroitin sulfate | ADAMTS12 HGF THBS1 THBS2 FN1 ADAMTS3 SEMA5B ADAMTS7 LAMA4 ADAMTS18 NGLY1 AGRN | 8.62e-09 | 413 | 74 | 12 | CID000024766 |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 3.97e-06 | 200 | 74 | 7 | 5991_UP | |
| Drug | Smoke | ADAMTS12 USP31 HGF THBS1 THBS2 MAST4 FN1 ADAMTS3 EGFR PCLO CXCL9 LAMA4 PCOLCE2 | 9.11e-06 | 937 | 74 | 13 | ctd:D012906 |
| Drug | S-dC28 | 9.21e-06 | 13 | 74 | 3 | CID000159480 | |
| Drug | DB04780 | 1.93e-05 | 170 | 74 | 6 | CID005459389 | |
| Drug | tegafur | 1.95e-05 | 49 | 74 | 4 | CID000005386 | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.06e-05 | 194 | 74 | 6 | 3284_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 4.17e-05 | 195 | 74 | 6 | 5574_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 4.17e-05 | 195 | 74 | 6 | 4124_UP | |
| Drug | THIP Hydrochloride; Up 200; 22.6uM; HL60; HT_HG-U133A | 4.29e-05 | 196 | 74 | 6 | 3132_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 4697_UP | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | 4.81e-05 | 200 | 74 | 6 | 5510_DN | |
| Drug | PHA665752 | 5.57e-05 | 23 | 74 | 3 | CID010461815 | |
| Disease | body fat distribution | 5.28e-07 | 202 | 70 | 7 | EFO_0004341 | |
| Disease | vital capacity | ADAMTS10 THBS1 THBS2 ADAMTSL1 PCDHA9 FN1 ADAMTS3 ADAMTS6 PCLO ADAMTS15 ADAMTS18 ADAMTSL3 SLC2A12 FBN3 | 1.02e-06 | 1236 | 70 | 14 | EFO_0004312 |
| Disease | alpha-tocopherol measurement | 1.42e-05 | 20 | 70 | 3 | EFO_0007898 | |
| Disease | cortical surface area measurement | HGF THBS1 ADAMTSL1 MAST4 ADAMTS3 EGFR ADAMTS7 ADAMTS18 NTN1 DYSF ADAMTSL3 FBN3 RHOT1 | 1.45e-05 | 1345 | 70 | 13 | EFO_0010736 |
| Disease | Hennekam syndrome (is_implicated_in) | 1.66e-05 | 3 | 70 | 2 | DOID:0060366 (is_implicated_in) | |
| Disease | Hennekam lymphangiectasia-lymphedema syndrome | 1.66e-05 | 3 | 70 | 2 | C0340834 | |
| Disease | Squamous cell carcinoma of esophagus | 7.86e-05 | 95 | 70 | 4 | C0279626 | |
| Disease | Cystic kidney | 8.27e-05 | 6 | 70 | 2 | C0022679 | |
| Disease | body composition measurement | 9.75e-05 | 193 | 70 | 5 | EFO_0005106 | |
| Disease | cathepsin H measurement | 1.16e-04 | 7 | 70 | 2 | EFO_0020243 | |
| Disease | diabetes mellitus (is_marker_for) | 1.28e-04 | 41 | 70 | 3 | DOID:9351 (is_marker_for) | |
| Disease | Malignant mesothelioma | 1.34e-04 | 109 | 70 | 4 | C0345967 | |
| Disease | waist-hip ratio | ADAMTS10 MAST4 SCUBE2 FN1 DNAH10 ADAMTS6 SDCCAG8 NSD1 LAMA4 ATP1B2 ADAMTSL3 | 1.39e-04 | 1226 | 70 | 11 | EFO_0004343 |
| Disease | DNA methylation | 1.61e-04 | 656 | 70 | 8 | GO_0006306 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 2.07e-04 | 122 | 70 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 2.13e-04 | 123 | 70 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | Cystic Kidney Diseases | 3.01e-04 | 11 | 70 | 2 | C1691228 | |
| Disease | brain measurement, neuroimaging measurement | 3.27e-04 | 550 | 70 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | brain cortex volume measurement | 4.25e-04 | 13 | 70 | 2 | EFO_0010287 | |
| Disease | COVID-19 (is_marker_for) | 4.58e-04 | 63 | 70 | 3 | DOID:0080600 (is_marker_for) | |
| Disease | glycerate measurement | 5.71e-04 | 15 | 70 | 2 | EFO_0021029 | |
| Disease | developmental dysplasia of the hip | 6.52e-04 | 16 | 70 | 2 | EFO_1000648 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 6.52e-04 | 16 | 70 | 2 | C0751885 | |
| Disease | Diabetic Angiopathies | 6.52e-04 | 16 | 70 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 6.52e-04 | 16 | 70 | 2 | C0025945 | |
| Disease | forced expiratory volume, response to bronchodilator | 6.60e-04 | 445 | 70 | 6 | EFO_0004314, GO_0097366 | |
| Disease | lung cancer (is_implicated_in) | 7.35e-04 | 74 | 70 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.35e-04 | 74 | 70 | 3 | DOID:3748 (is_marker_for) | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 7.37e-04 | 17 | 70 | 2 | C0751883 | |
| Disease | Leukemia, Myelocytic, Acute | 7.74e-04 | 173 | 70 | 4 | C0023467 | |
| Disease | 4-ethylphenylsulfate measurement | 8.28e-04 | 18 | 70 | 2 | EFO_0021148 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 8.28e-04 | 18 | 70 | 2 | OBA_2045155 | |
| Disease | Glioblastoma | 8.89e-04 | 79 | 70 | 3 | C0017636 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 9.24e-04 | 19 | 70 | 2 | C0751884 | |
| Disease | Neoplasm Invasiveness | 9.73e-04 | 184 | 70 | 4 | C0027626 | |
| Disease | Giant Cell Glioblastoma | 1.06e-03 | 84 | 70 | 3 | C0334588 | |
| Disease | parental longevity | 1.13e-03 | 494 | 70 | 6 | EFO_0007796 | |
| Disease | sexual dimorphism measurement | ADAMTS10 DNAH10 ADAMTS3 CD248 LIPG NSD1 ATP1B2 DYSF ADAMTSL3 | 1.18e-03 | 1106 | 70 | 9 | EFO_0021796 |
| Disease | prostate carcinoma | 1.21e-03 | 891 | 70 | 8 | EFO_0001663 | |
| Disease | cortical thickness | THBS1 MAST4 ADAMTS3 EGFR ADAMTS7 LRP4 ADAMTS18 DYSF ADAMTSL3 | 1.23e-03 | 1113 | 70 | 9 | EFO_0004840 |
| Disease | urate measurement | 1.25e-03 | 895 | 70 | 8 | EFO_0004531 | |
| Disease | Colorectal Carcinoma | 1.37e-03 | 702 | 70 | 7 | C0009402 | |
| Disease | Myasthenic Syndromes, Congenital | 1.48e-03 | 24 | 70 | 2 | C0751882 | |
| Disease | lobe attachment | 1.50e-03 | 207 | 70 | 4 | EFO_0007667 | |
| Disease | Cerebral Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0750936 | |
| Disease | Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.61e-03 | 25 | 70 | 2 | C0547065 | |
| Disease | Periodontal Pocket | 1.61e-03 | 25 | 70 | 2 | EFO_1001393 | |
| Disease | Pilocytic Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.61e-03 | 25 | 70 | 2 | C0338070 | |
| Disease | body fat percentage, high density lipoprotein cholesterol measurement | 1.61e-03 | 25 | 70 | 2 | EFO_0004612, EFO_0007800 | |
| Disease | glycerol measurement | 1.74e-03 | 26 | 70 | 2 | EFO_0010115 | |
| Disease | Gemistocytic astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.74e-03 | 26 | 70 | 2 | C0334582 | |
| Disease | obesity (is_marker_for) | 1.80e-03 | 101 | 70 | 3 | DOID:9970 (is_marker_for) | |
| Disease | Anaplastic astrocytoma | 1.87e-03 | 27 | 70 | 2 | C0334579 | |
| Disease | coronary artery disease | 2.00e-03 | 1194 | 70 | 9 | EFO_0001645 | |
| Disease | facial width measurement | 2.02e-03 | 105 | 70 | 3 | EFO_0007855 | |
| Disease | urinary bladder cancer (is_marker_for) | 2.13e-03 | 107 | 70 | 3 | DOID:11054 (is_marker_for) | |
| Disease | corneal topography | 2.24e-03 | 109 | 70 | 3 | EFO_0004345 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.25e-03 | 566 | 70 | 6 | EFO_0007660, EFO_0008354 | |
| Disease | white matter microstructure measurement | 2.35e-03 | 390 | 70 | 5 | EFO_0005674 | |
| Disease | Glioblastoma Multiforme | 2.36e-03 | 111 | 70 | 3 | C1621958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CGRGNCRVANAEEKL | 16 | P30926 | |
| CSLTCGQGLQVRTRS | 321 | O60241 | |
| LQRAQGGTCLKACAS | 451 | Q9BWT7 | |
| QCPKNGTAVCATNRR | 66 | P05156 | |
| TCGSSALQGQRRNKR | 51 | Q8IYX3 | |
| QCCARSQKSGIRLQG | 111 | O95971 | |
| VQCQAGRGASLLCVK | 201 | Q9HCU0 | |
| CQNGGSCLRRLAVSS | 3811 | Q6V0I7 | |
| LQKVRSGQCQGRDQC | 381 | O00468 | |
| LVLKNCCAQSGNTRR | 301 | Q9UKB5 | |
| VQSLLCNTGSRCRNF | 71 | Q86UQ4 | |
| AAKVVCRQLGCGRAV | 171 | O43866 | |
| CRQLGCGRAVLTQKR | 176 | O43866 | |
| ICANGICINQIGSFR | 1731 | Q75N90 | |
| CPNNSQSCGRIVRVK | 1476 | Q96F81 | |
| SAQCGVGQRQRSVRC | 1016 | Q9H324 | |
| CSRNCSGGFKIREIQ | 1376 | P58397 | |
| RSCGKLGVQTRGIQC | 921 | Q8WXS8 | |
| TCGGGVQLARRQCTN | 531 | Q8TE58 | |
| ACAGGQQSRKIQCVQ | 946 | Q8TE60 | |
| CAGGVQRQEVVCKRL | 856 | Q9UKP5 | |
| TKCTVTCGRGVQRQN | 831 | Q9UKP4 | |
| GRKSGGVCLNCRHNT | 361 | O95631 | |
| PAGGRCQNQCFSKRQ | 1926 | Q96L73 | |
| SQQRRQRVCSGEGKQ | 751 | Q9Y5H5 | |
| CNKLCGRGQSRQLSP | 601 | Q8TD20 | |
| CRKGATCINGVNGFR | 691 | Q04721 | |
| EGRQLQADGKSCNRC | 366 | O95460 | |
| NNVLCSKCGGQTRSR | 246 | Q96IV0 | |
| RKSGQFCDVRLQVCG | 26 | Q9Y6Y0 | |
| TNRCNAGVCALNGKL | 451 | Q9Y6Y0 | |
| PKRACQFNRTQLGNC | 146 | P14415 | |
| CGGGVQTRRVTCQKL | 1561 | Q8N6G6 | |
| CLNCQTQRAISGQLG | 1106 | Q9Y6V0 | |
| LRCQKQRGASASSGQ | 336 | C9JC47 | |
| RNVFRCNVIGVKNCG | 416 | Q8IXI2 | |
| CLCNLRGGALKQTKN | 756 | Q9H3R0 | |
| GICLSCRKNRCNSIG | 306 | Q9Y5X9 | |
| ALGQGSFSVCRRCRQ | 416 | O75676 | |
| TADQCANRCTRNKGL | 66 | P14210 | |
| LCQQKCRRTGTLEGN | 296 | Q9UKZ9 | |
| CQLCTGRQINCRNLG | 36 | Q7Z2Q7 | |
| GKTLALLQTGCCRNL | 186 | Q96CB9 | |
| TKIICAQQCSGRCRG | 211 | P00533 | |
| TCGTGVRFRTRQCNN | 566 | O15072 | |
| LRRECRIGNGQCKNQ | 31 | Q30KQ9 | |
| NRGNLLQCICTGNGR | 251 | P02751 | |
| CRTSNRKSLIGNGQS | 226 | O15021 | |
| VRKGRCSCISTNQGT | 26 | Q07325 | |
| KTQCNIAQCKRLDGG | 3036 | Q8IVF4 | |
| ITQCKNRRCGGELGD | 801 | Q9NQ36 | |
| CGGQTVQSCVIRNLR | 1361 | O75923 | |
| QQSGRSKCLKCGGSR | 51 | Q8N5C7 | |
| TGQCRNCLRNTTGFK | 206 | Q16363 | |
| CQLCGGKFTQQRNLI | 591 | Q96JB3 | |
| NSGQCKCKANVIGLR | 711 | O75445 | |
| NQGSFCNGCKRLLTV | 391 | Q6NUJ1 | |
| LAANTCNRVGGLCLK | 271 | Q86SQ7 | |
| AARNLCRGAGCNRQA | 186 | Q5T036 | |
| GRRCSCGTNGNLQLN | 1016 | Q9C0B9 | |
| VTCGGGVQKRSRLCN | 506 | P07996 | |
| CIACGVNLNSSRQSR | 241 | O15393 | |
| ANVGTCQAVLCRGGK | 896 | Q6ZVD8 | |
| RGCDVNLKEQGQLRC | 991 | Q96PX9 | |
| NRCSVLRQLGCKDGK | 326 | Q6IQ16 | |
| LRICRVNKNCGSVRG | 186 | Q04864 | |
| GMQSRRRACENGNSC | 741 | Q9P283 | |
| VCGSQQGRGQCTEVR | 51 | P40126 | |
| ANVGKCQTVLCRNGK | 1286 | O60346 | |
| CNRACTGQQGKRFGL | 461 | Q70CQ4 | |
| VTCGVGNITRIRLCN | 451 | P35442 | |
| CGGGTQSRKIRCVNT | 1081 | Q9C0I4 | |
| CNLCGKRFMQRIGLQ | 386 | A6NGD5 | |
| GLTCKGIRCEKQNNA | 546 | Q9UBN4 | |
| CCRQAVQGRQGRGVT | 81 | Q6ZVH6 | |
| CSVSCGVGIQRRKQV | 831 | P82987 | |
| NGRCIGQRKLCNGVN | 321 | O75096 |